First Time Loading...

Lyra Therapeutics Inc
NASDAQ:LYRA

Watchlist Manager
Lyra Therapeutics Inc Logo
Lyra Therapeutics Inc
NASDAQ:LYRA
Watchlist
Price: 0.3558 USD -4.35% Market Closed
Updated: May 16, 2024

Lyra Therapeutics Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lyra Therapeutics Inc
EPS (Diluted) Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Lyra Therapeutics Inc
NASDAQ:LYRA
EPS (Diluted)
-$1
CAGR 3-Years
21%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
EPS (Diluted)
$15
CAGR 3-Years
41%
CAGR 5-Years
24%
CAGR 10-Years
12%
Bristol-Myers Squibb Co
NYSE:BMY
EPS (Diluted)
-$3
CAGR 3-Years
-3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
EPS (Diluted)
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
EPS (Diluted)
$0
CAGR 3-Years
-31%
CAGR 5-Years
-23%
CAGR 10-Years
-5%
Eli Lilly and Co
NYSE:LLY
EPS (Diluted)
$6
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
7%

See Also

What is Lyra Therapeutics Inc's EPS (Diluted)?
EPS (Diluted)
-1.3 USD

Based on the financial report for Dec 31, 2023, Lyra Therapeutics Inc's EPS (Diluted) amounts to -1.3 USD.

What is Lyra Therapeutics Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-21%

Over the last year, the EPS (Diluted) growth was 31%. The average annual EPS (Diluted) growth rates for Lyra Therapeutics Inc have been 21% over the past three years , -21% over the past five years .